Skip to content

Elizabeth Warren has a problem with innovators of big expensive COVID vaccines taking out intellectual property protections for their efforts. A few days ago, the leftist senator said this, according to this baleful editorial published in The Wall Street Journal: “Special [IP] protections for drug companies are an even bigger issue than COVID-19 alone,” the Massachusetts Senator said at a Senate Finance hearing with U.S. Trade Rep Katherine Tai on Wednesday. “I think it’s time now for our trade negotiators to take leadership and actively set rules that lower drug costs for American families.” What special protections? Drug makers receive less IP protection than other businesses under World Trade Organization (WTO) rules, which allow low-income countries to force drug makers to license patents during emergencies. But progressives believe IP protections shouldn’t exist at all for drugs and that their makers shouldn’t be rewarded for years of risky investment and innovation. As Ms. Warren explained: “We’re fighting over a waiver to [IP] rules—rules that never should have existed in the first place.”

Notifications - Subscriptions
Notify of
Oldest Most Voted
Inline Feedbacks
View all comments

Would love your thoughts, please comment.x